Andere talen BioMarin Pharmaceutical Inc.

Aandelen

BMRN

US09061G1013

Farmaceutische producten

Geschatte realtime Cboe BZX Andere beurzen 16:20:43 23-01-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
56,74 ^USD	-0,78%		+4,40%	-4,11%

20/01	BIOMARIN PHARMACEUTICAL INC. : Canaccord Genuity zet aandeel op kooplijst	ZM
13/01	BioMarin Pharmaceuticals Streeft naar Aanhoudende Groei in 2026, aldus Wedbush	MT

Andere talen

21/01	When America Starts to Feel Like a Risky Asset
20/01	Greenland, Tariffs, and the Quiet Revolt of the Bond Market
20/01	Analyst recommendations: Intel, Philip Morris, Duolingo, Netflix, SanDisk…
13/01	BioMarin Pharmaceuticals Aims for Sustained Growth in 2026, Wedbush Says
13/01	BioMarin Pharmaceutical Reports Preliminary 2025 Revenue, Details Asset Write-Down
12/01	Biomarin Pharmaceutical Inc estimates $3.2 billion in total revenues for FY - SEC filing
12/01	BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer
12/01	BioMarin Appoints Arpit Davé Chief Digital and Information Officer
12/01	BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer
08/01	BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
08/01	Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership
08/01	Veeva and Biomarin form long-term strategic partnership
08/01	Veeva and BioMarin Form Long-Term Strategic Partnership
22/12	BioMarin Pharmaceutical Inc. Announces its Decision to Discontinue Development of BMN349
19/12	Health Care Up Amid Deal Activity -- Health Care Roundup
19/12	MÄRKTE USA/Zinssenkungshoffnung stützen Börse - Oracle fest
19/12	Sector Update: Health Care Stocks Rise Late Afternoon
19/12	Sector Update: Health Care Stocks Higher Friday Afternoon
19/12	Sector Update: Health Care
19/12	Top Midday Gainers
19/12	MÄRKTE USA/Börsen von Zinssenkungshoffnung gestützt - Oracle fest
19/12	Top Midday Stories: Oracle, Others Form JV to Oversee TikTok in US; More Drugmakers to Announce US Drug Price Deals
19/12	BioMarin Pharmaceutical Inc. submitted a non-binding indication of interest to acquire Amicus Therapeutics, Inc. from The Vanguard Group, Inc., Wellington Management Group LLP, BlackRock, Inc., William Blair Investment Management, LLC, and others for $4.7 billion.
19/12	BioMarin Pharmaceutical to Acquire Amicus Therapeutics in $4.8 Billion Deal
19/12	BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 Billion; Shares Jump

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen MarketScreener-artikels MarketScreener-analyses Ideeën voor de handel

Andere talen BioMarin Pharmaceutical Inc.

Aandelen

BMRN

US09061G1013

Farmaceutische producten

Andere talen

Filters